Nucleic Acid and Nuclease Decontamination in Biopharmaceutical Manufacturing and Molecular Testing Workflows

In biopharmaceutical processes and high-sensitivity molecular testing systems, the forms in which nucleic acids and nucleases exist and the ways they are controlled directly determine manufacturability, product safety, and analytical credibility. High–molecular-weight DNA/RNA can markedly alter rheology, compromise purification and separation, and introduce host-residual risk. Conversely, trace DNase/RNase activity can be sufficient to destroy the integrity of nucleic-acid therapeutics and sequencing libraries, or generate hard-to-trace false negatives/false positives in PCR/qPCR workflows. For these reasons, “nucleic acid/nuclease removal” should be elevated from ad hoc practices to a designed, verifiable, and scalable engineering module.

I. Fundamental Concepts

1.1 Terminology and control objectives

In biopharmaceutical and molecular biology settings, “nucleic acid/nuclease decontamination” encompasses two distinct control targets:

(1) Nucleic acid (DNA/RNA) removal

Reducing free or bound nucleic acids via degradation, separation, or adsorption, with core objectives including:

① lowering lysate viscosity to improve mixing, centrifugation, filtration, and chromatography unit operations;

② removing host cell DNA (HCDNA) to meet pharmacopeial/regulatory limits;

③ minimizing interference from nucleic acid–protein/particle complexes in downstream analytics, formulation stability, and safety.

(2) Nuclease removal (DNase/RNase control)

Reducing or eliminating DNase/RNase activity to protect target nucleic acids (plasmid DNA, mRNA, siRNA, viral genomes, sequencing libraries, etc.) from degradation. Key objectives include:

① establishing an operational environment approximating RNase-free/DNase-free conditions;

② controlling exogenous or host-derived nuclease contamination in nucleic-acid drug processes;

③ preventing residual process nucleases added upstream from carrying into downstream critical steps.

1.2 Two dimensions: in-solution versus environmental/surface control

By the physical carrier, control can be further divided into:

(1) In-solution control of nucleic acids/nucleases

Targeting nucleic acids and nuclease activity in fermentation supernatants, cell lysates, intermediate solutions, buffers, and other liquid-phase matrices.

(2) Solid-surface and environmental control

Targeting adsorbed or dried nucleic acids and nucleases on benches, instrument housings, pipettes, centrifuge chambers, and consumable surfaces—critical to preventing false-positive amplification and RNase cross-contamination.

The following sections address these two dimensions in parallel.

II. Nucleic Acid Removal: From “Viscosity Reduction by Shearing” to Process Polishing

2.1 Enzymatic degradation: converting long-chain nucleic acids into short fragments

(1) Basic principle

Following cell lysis or crude clarification, nonspecific DNases, RNases, or broad-spectrum endonucleases are added to cleave high–molecular-weight DNA/RNA into short oligonucleotide fragments. This can substantially reduce viscosity and improve rheological behavior and mass transfer across downstream unit operations.

(2) Critical process parameters

① Metal-ion dependence

Most endonucleases require divalent cations (Mg²⁺/Mn²⁺). Chelators such as EDTA can markedly suppress activity. Process design should therefore coordinate chelator usage with the intended nuclease operating window.

② Substrate accessibility

When nucleic acids exist within nucleoprotein complexes, are membrane-associated, or are capsid-encapsulated, nucleases may have limited access. Typical enabling measures include:

surfactants or mild detergents to disrupt structures;

adjusting ionic strength/pH to improve solubilization and dissociation;

mechanical disruption to increase exposure.

③ Reaction conditions and time

Temperature, pH, ionic strength, and incubation time collectively determine the degree of degradation. In manufacturing, the operating window is usually selected to balance “meaningful viscosity reduction” with “residual nucleic acids removable by downstream steps.”

(3) Representative applications

① recombinant proteins/antibodies: viscosity reduction pre- or post-clarification to increase centrifugation/filtration flux and chromatographic controllability;

② viral vectors/VLPs: reducing host nucleic acid burden and viscosity to ease chromatography and membrane separation;

③ high-density cell cultures at harvest: improving flowability and mixing efficiency in large-volume handling.

2.2 Adsorption and precipitation: leveraging strong negative charge and polyanionic behavior of nucleic acids

(1) Adsorption by positively charged materials

At near-neutral pH, nucleic acids carry dense negative charge and can be captured via:

① Anion exchange chromatography (AEX)

Electrostatic interactions enable nucleic acid binding with target molecules in flow-through (or the inverse mode, depending on product and conditions).

② Cationic functionalized media or polycationic surfaces

Used to adsorb free nucleic acids or nucleic acid–protein complexes for pretreatment or inline decontamination modules.

A key risk is co-adsorption of target molecules (especially those with net negative charge), potentially impacting yield. Robust separation windows are established via optimization of pH, conductivity, and gradients.

(2) Polycation precipitation

Polycations such as polyethylenimine (PEI) form insoluble complexes with nucleic acids and are useful for large-volume lysate pretreatment.

① Advantages: substantial nucleic acid load reduction and viscosity decrease; relatively scalable.

② Risks: excessive dosing or inappropriate conditions can co-precipitate negatively charged proteins, polyanions, or particles, causing yield/activity losses. Online conductivity/pH monitoring and scale-informed DOE are typically required to define a robust operating region.

2.3 Physical separation: polishing based on size and charge differences

(1) Ultrafiltration/diafiltration (UF/DF)

For nuclease-cleaved short fragments, UF/DF can remove nucleic acids effectively. In contrast, intact high–molecular-weight DNA can accelerate membrane fouling and rapid TMP increase. Consequently, a common engineering approach is “enzymatic pretreatment + UF/DF polishing.”

(2) Chromatographic polishing

① AEX polishing: by optimizing load, salt gradient, and pH, residual nucleic acids can be separated from proteins/particles to meet host DNA limits.

② SEC: provides additional removal of nucleic acids and complexes through size exclusion, but is typically limited by throughput and load capacity and is therefore more common in analytics or small-scale preparation.

III. Nuclease Control: Inactivation, Removal, and System-Level Prevention

3.1 Nuclease inactivation: mechanism-informed inhibition

(1) Metal-dependent nucleases

For nucleases requiring divalent cations, chelators such as EDTA inhibit activity by sequestering metal ions. This approach is broadly applicable to many nonspecific endonucleases but may be less effective for non-metal-dependent RNases (e.g., RNase A family) or enzymes with exceptionally high metal affinity.

(2) Denaturation and conformational disruption

Heat, chaotropes (guanidinium salts), urea, or anionic detergents can disrupt nuclease structure and eliminate catalytic activity. Process design must evaluate:

① impacts on target nucleic acid secondary structure and function;

② compatibility with downstream enzymatic workflows (reverse transcription, PCR, ligation, in vitro transcription, etc.).

(3) Control of highly stable RNases

Some RNases exhibit strong thermostability and extensive disulfide bonding; mild heating or short treatments may be insufficient for full inactivation. In RNA-centric processes, emphasis should therefore be placed on source control and migration blockade (area segregation, dedicated consumables, surface decontamination), rather than relying on a single terminal inactivation step.

3.2 Process removal of nucleases

(1) Chromatography and membrane separation

Exploiting differences between nucleases and target nucleic acids in MW, pI, and hydrophobicity:

① AEX/HIC and related modes: conditions can be tuned so nucleases bind while nucleic acids flow through (or vice versa), particularly relevant when exogenous process nucleases were introduced upstream.

② UF/DF: selecting an appropriate MWCO based on the relative sizes of nuclease proteins and nucleic acids enables partial nuclease reduction via concentration/diafiltration.

(2) Affinity and specific adsorption

If an exogenous nuclease carries a tag or known epitope, affinity chromatography or specific adsorption materials can be designed for targeted removal, improving predictability of residual control.

3.3 RNase contamination control as a systems program

(1) Facility and materials management

① dedicated RNA work areas, dedicated pipettes, centrifuge rotors, and consumables;

② verified RNase/DNase-free water and buffers across the workflow.

(2) Environmental and solid-surface control

① routine decontamination of high-touch/high-risk surfaces (PCR benches, clean benches, ice boxes, common work surfaces, pipette housings) using nucleic acid/nuclease decontamination reagents;

② fixed-frequency surface-cleaning SOPs with execution records.

(3) Monitoring and traceability

① negative controls at critical nodes (e.g., no-template controls) to monitor background amplification and nonspecific degradation;

② integrity/activity testing for anomalous batches, combined with operational logs to identify contamination points, followed by corrective actions such as “source replacement + deep cleaning + process revision.”

IV. Solid-Surface Nucleic Acid/Nuclease Cleaning and Environmental Governance

4.1 Characteristics and risks of solid-surface contamination

(1) Contamination forms

DNA/RNA commonly adhere and dry on plastic, glass, and metal surfaces; simple rinsing is often insufficient. Dried RNases can retain substantial activity for extended periods.

(2) Risk manifestations

① dried DNA (particularly amplicons) can act as PCR/qPCR templates, causing false positives;

② surface RNases introduced into reactions can rapidly degrade RNA, leading to unexplained failures or quantitative bias.

4.2 Mechanisms of surface decontamination reagents

(1) Desorption and transfer into the liquid phase

Surfactant components reduce interfacial tension and disrupt weak interactions between nucleic acids/proteins and solid surfaces, releasing contaminants into the liquid phase.

(2) Chemical degradation and enzyme inactivation

Active components can chemically degrade or modify nucleic acids (e.g., backbone cleavage or base modification), reducing their ability to serve as amplification templates; concurrently, they disrupt nuclease structure or critical residues to inactivate enzymatic activity.

(3) Physical removal

After sufficient contact time, wiping or rinsing removes the contaminant-containing liquid phase, achieving practical removal of nucleic acids and nucleases.

4.3 Selection logic for surface decontamination reagents

Based on the primary control objective, usage strategies can be summarized into three categories:

(1) Nucleic-acid–focused removal

Appropriate when environmental DNA/RNA background control is the main concern, while minimizing potential impacts on nearby enzymatic reagents (e.g., surfaces near post-amplification operations).

(2) Nuclease-focused removal

Appropriate for RNA workspaces and routine nucleic acid preparation areas, prioritizing RNase/DNase risk reduction while avoiding excessive damage to nearby nucleic acid standards and samples.

(3) Dual removal of nucleic acids + nucleases

Appropriate for ultra-sensitive nucleic acid detection platforms or high-risk cross-contamination areas requiring simultaneous reduction of solid-surface nucleic acid and nuclease risks. These products often demand stricter operational discipline; after use, thorough wiping/appropriate rinsing and replacement of gloves/consumables are recommended to prevent reagent carryover into reaction systems.

V. Process-Level Combination Strategies: From Single Tools to Integrated Solutions

5.1 Integrated de-nucleic-acid workflows for protein/viral products

In protein therapeutics, antibodies, and viral vectors, a robust nucleic acid control pathway often takes a three-stage form: enzymatic pretreatment – adsorption/precipitation – terminal polishing.

(1) Pretreatment

Add nuclease following lysis/harvest and optimize Mg²⁺, temperature, and time to adequately shear high–molecular-weight nucleic acids and reduce viscosity.

(2) Midstream separation

Introduce polycation precipitation or cationic adsorption to remove nucleic acids and nucleic acid–protein complexes, then lock the operating window using online monitoring (conductivity, pH, viscosity).

(3) End polishing

Use polishing units such as AEX and UF/DF to drive residual nucleic acids below regulatory thresholds while also monitoring and removing potential residual exogenous process nucleases.

5.2 De-nuclease strategies for nucleic-acid products

For plasmids, mRNA, and siRNA, nuclease contamination control is primary and can be summarized as:

(1) Prevention

Area segregation, dedicated consumables, and routine surface decontamination to reduce the probability of RNase/DNase introduction.

(2) In-process monitoring

Nuclease activity testing and nucleic acid integrity checks at critical nodes (water, buffers, intermediates) to form an internal control loop.

(3) Terminal control

Strict environmental and operational controls during final formulation and filling, with dedicated cleaning validation of process vessels and transfer systems when required.

VI. Testing and Release: Defining “Removal Level” with Quantitative Criteria

6.1 Quantification and characterization of residual nucleic acids

(1) qPCR/ddPCR

Mainstream methods for host cell DNA quantification. qPCR typically uses target-specific design and standard curves; ddPCR provides absolute quantification via partitioning and positive counts. Matrix effects should be corrected, and appropriate internal controls applied.

(2) Fluorescent dye assays

dsDNA-specific dyes provide rapid quantification for process monitoring, but are sensitive to fragment length and matrix interference and are generally insufficient as the sole release criterion.

(3) Electrophoresis/fragment analysis

Used to assess whether nucleic acids have been sufficiently sheared and to estimate the proportion of residual long-chain DNA, adding a structural dimension to evaluation of nuclease treatment.

6.2 Assessment of residual nucleases and background activity

(1) Functional activity assays

Using standard DNA/RNA substrates (including fluorogenic substrates) to monitor degradation rates provides the most risk-relevant readout and supports evaluation of RNase/DNase residual control.

(2) Specific protein assays

For known exogenous nucleases, immunoassays or targeted protein quantification can be used to assess residual levels; pairing these with functional assays improves interpretive robustness.

VII. Common Failure Modes and Troubleshooting Pathways

(1) Persistently high viscosity or severe filtration/chromatography blockage

① verify nuclease operating conditions (Mg²⁺, temperature, time, presence of EDTA);

② assess whether viscosity is primarily nucleic-acid–driven or due to polysaccharides, cell debris, or other high-viscosity components.

(2) Unexpected degradation of target nucleic acids

① prioritize RNase source investigation: consumables, water, bench surfaces, operating practices;

② verify whether process nucleases lacked adequate inactivation/removal prior to UF/DF or chromatography.

(3) Yield loss following nucleic-acid removal measures

Common in polycation precipitation or overly aggressive AEX conditions. Use pH–conductivity two-dimensional optimization and load scanning to define a separation window between nucleic acids and the target molecule.

(4) Large batch-to-batch variability in nucleic acid or nuclease assay results

Often linked to inconsistent sampling points, inconsistent preprocessing, or shifts in standard curve systems. Correct via standardized sampling SOPs, unified matrix calibration, and method validation.

VIII. Aladdin-Related Products

Catalog No.	Product Name	Grade and Purity	Primary Coverage	Recommended Use Scenarios
N598128	RNA and DNA Away	BioReagent, ready-to-use	Removal of RNA/DNA contamination (residual nucleic acids)	Reducing nucleic acid residues on benches/tools and cross-sample contamination; suitable for PCR false-positive risk control, nucleic acid background control, and routine cleaning of nucleic-acid operation areas
R749971	RNase and DNase Away	BioReagent, ready-to-use	Removal/inactivation of RNase/DNase (nuclease risk)	Cleaning of workspaces and tools for RNase-sensitive workflows (RNA extraction, library prep, in vitro transcription); also suitable to protect DNA samples from DNase impact
R749976	RNase, DNase, RNA and DNA Away	BioReagent, ready-to-use	Full coverage: residual nucleic acids + nucleases	Shared platforms running parallel RNA/DNA workflows; recommended as a default cleaning standard to unify SOPs, reduce operational variability, and mitigate cross-contamination risk
R749975	RNase, DNase and DNA Away	BioReagent, ready-to-use	Nuclease risk + DNA residues (DNA-leaning workflows)	DNA-centric workflows requiring RNase/DNase control; institutionalized cleaning and background control for PCR/molecular cloning/plasmid-related areas

Overall, nucleic acid and nuclease control should not be treated merely as “cleaning” or auxiliary work. It should be integrated into top-level process development and platform design: upstream determines load, midstream converts and separates, and downstream polishing and environmental governance drive residual risk to a level appropriate for the intended use. Only when objectives are clearly decomposed, measures are rationally combined, and release criteria are quantifiable can “nucleic acid/nuclease removal” shift from reactive remediation to proactive design—supporting long-term operation of high-quality biomanufacturing and high-credibility nucleic acid testing systems.

Aladdin: https://www.aladdinsci.com/